BCCT plans to write a summary on magnolia bark (honokiol). While our summary is in development, you can visit About Herbs: Magnolia officinalis
The About Herbs summary for Magnolia states that “due to inhibition of several enzymes or pathways for drug metabolism, there is the potential for interactions with many medications.” For more information, refer to the Magnolia summary.
BCCT does not recommend therapies or doses, but only provides information for patients and providers to consider as part of a complete treatment plan. Patients should discuss therapies with their physicians, as contraindications, interactions and side effects must be evaluated.
Dosage recommendations are available from these sources:
- Block KI. Life over Cancer: The Block Center Program for Integrative Cancer Care. New York: Bantam Dell. 2009.
- Natural Medicines Database (requires purchase)
Integrative Plans, Protocols and Medical Systems
|For more information about plans and protocols, see our Integrative Plans and Protocols page.|
- Plans, protocols and programs
- Traditional systems
- Clinical Trials.gov trials for magnolia
- Moss Reports (purchase required): Select from the list of cancers down the left side of the page for a report describing uses of conventional, complementary, alternative and integrative therapies related to that cancer. Ralph Moss is among the most knowledgeable and balanced researchers of integrative cancer therapies. The cost of his Moss Reports is not negligible, but many patients find them of considerable value. Moss is also available for consultations. The Moss Reports describes Honokiol use in killing cancer stem cells.
- Memorial Sloan Kettering Cancer Center: About Herbs, Botanicals and Other Products
- Therapeutic Research Center: Natural Medicines Database
- Neil McKinney, BSc, ND: Naturopathic Oncology, 3rd Edition